Bilastine vs. Hydroxyzine: A comparison of sedative effect using occupation of brain histamine H1 Receptors in healthy volunteers.

Trial Profile

Bilastine vs. Hydroxyzine: A comparison of sedative effect using occupation of brain histamine H1 Receptors in healthy volunteers.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 May 2014

At a glance

  • Drugs Bilastine (Primary) ; Hydroxyzine
  • Indications Allergic rhinoconjunctivitis; Urticaria
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors FAES Farma
  • Most Recent Events

    • 27 May 2014 New trial record
    • 15 May 2014 Primary endpoint 'Receptor-occupancy' has been met.
    • 15 May 2014 Results published in the British Journal of Clinical Pharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top